Cover Image
市場調查報告書

歐洲的HIV/AIDS診斷市場(醫院·血液銀行·公立/民間實驗所·開業醫生):主要的免疫診斷·核酸增幅檢查(NAT)治療相關供應商的市場佔有率·銷售額的預測

2018 Europe HIV/AIDS Diagnostic Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

出版商 Venture Planning Group 商品編碼 273962
出版日期 內容資訊 英文 277 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
歐洲的HIV/AIDS診斷市場(醫院·血液銀行·公立/民間實驗所·開業醫生):主要的免疫診斷·核酸增幅檢查(NAT)治療相關供應商的市場佔有率·銷售額的預測 2018 Europe HIV/AIDS Diagnostic Testing Market: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
出版日期: 內容資訊: 英文 277 Pages
簡介

本報告提供歐洲主要5個國家的各種醫療機關(醫院·血液銀行(Blood Banks)·公立/民間實驗所·開業醫生等等)HIV/AIDS診斷上的市場相關分析,提供疾病概要和治療方法,技術開發·活用的最新情形,市場趨勢預測(今後5年份),主要業者的市場佔有率,今後的市場機會與課題,再加上主要企業簡介與市場策略等資訊彙整,為您概述為以下內容。

簡介

全球市場·技術概要

  • 背景
  • 診斷檢驗法:HIV-1/2,HIV Ag,核酸增幅檢查(NAT),西方墨點法
  • 疫苗及藥物
  • 診斷設備的檢討和市場需求
  • 新的診斷技術

法國市場:市場規模·成長率,主要業者的銷售額與市場佔有率

德國市場:市場規模·成長率,主要業者的銷售額與市場佔有率

義大利市場:市場規模·成長率,主要業者的銷售額與市場佔有率

西班牙市場:市場規模·成長率,主要業者的銷售額與市場佔有率

英國市場:市場規模·成長率,主要業者的銷售額與市場佔有率

替代性的市場普及策略

  • 內部開發
  • 合資企業協定
  • 與大學的契約
  • 分散式檢查市場流通策略
    • 行銷的方法
    • 產品的複雜性
    • 客戶的偏好
    • 既有廠商
    • 新加入廠商
    • 經銷商的主要類型
    • 市場細分化

加入市場的潛在障礙與風險

  • 市場的成熟度
  • 成本控制
  • 競爭
  • 最尖端科技及其限制
  • 專利保護
  • 法規的限制
  • 分散式檢查市場課題

競爭企業分析

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 榮研化學
  • Enzo Biochem
  • FUJIREBIO/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • TaKaRa BIO
  • Thermo Fisher
  • Wallac/PE
  • 和光純藥工業

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: VPID30171

Complete report $3,950.  DataPack (test volumes, sales forecasts, supplier shares) $2,500.

Summary

This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK).  The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:

- Hospitals - Public Health Labs - Commercial/Private Labs
- Blood Banks - Physician Offices - Ambulatory Care Centers

For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

  • Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
  • Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
  • Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho- Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
  • Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
  • Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including Venture Planning Group’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments.  The database contains information on companies, technologies, products and executives worldwide.  Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 277 pages and 31 tables

Table of Contents

I. Introduction

II. AIDS/HIV Worldwide Market and Technology Overview

  • A. Background
  • B. Diagnostic Tests: HIV-1/2/Combo , HIVAg/HIV NAT, Western Blot
  • C. Vaccines and Drugs
  • D. Instrumentation Review and Market Needs
  • E. Emerging Diagnostic Technologies

III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares

VI. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

VIII. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

IX. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

X. Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix/Erba
  • DiaSorin
  • Eiken Chemical
  • Elitech Group
  • Enzo Biochem
  • Fujirebio
  • Grifols
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech/Leica
  • Lonza
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

LIST OF TABLES

  • Major Companies Developing or Marketing AIDS Tests
  • France: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
  • France: HIV Ag Test Volume and Sales Forecasts By Market Segment
  • France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
  • France: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
  • France: AIDS Diagnostics Market by Major Supplier
  • France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
  • Germany: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
  • Germany: HIV Ag Test Volume and Sales Forecasts By Market Segment
  • Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales
  • Germany: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
  • Germany: AIDS Diagnostics Market by Major Supplier
  • Germany: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
  • Italy: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
  • Italy: HIV Ag Test Volume and Sales Forecasts By Market Segment
  • Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
  • Italy: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
  • Italy: AIDS Diagnostics Market by Major Supplier
  • Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
  • Spain: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
  • Spain: HIV Ag Test Volume and Sales Forecasts By Market Segment
  • Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
  • Spain: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
  • Spain: AIDS Diagnostics Market by Major Supplier
  • Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
  • UK: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
  • UK: HIV Ag Test Volume and Sales Forecasts By Market Segment
  • UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
  • UK: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
  • UK: AIDS Diagnostics Market by Major Supplier
  • UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Back to Top